ライフサイエンスコーパス: cryotherapy

1 hermy, laser ablation, cold coagulation, and cryotherapy).

2 chronous radiotherapy, scleral resection, or cryotherapy.

3 ia also were identified after treatment with cryotherapy.

4 ive approaches to prostate cancer, including cryotherapy.

5 approaches have also been employed for renal cryotherapy.

6 and probable side-effects they were offered cryotherapy.

7 f the cervix with acetic acid wash (VIA) and cryotherapy.

8 One patient underwent surgical cryotherapy.

9 d with early treatment failure after salvage cryotherapy.

10 emotherapy regimens, despite the use of oral cryotherapy.

11 e thermal ablation using the new device with cryotherapy.

12 cervical lesions or lesions appropriate for cryotherapy.

13 r biopsy that were treated successfully with cryotherapy.

14 excisional biopsy, partial sclerectomy, and cryotherapy.

15 ed conventionally, 50 eyes were treated with cryotherapy.

16 isional biopsy, superficial keratectomy, and cryotherapy.

17 formed in 9 eyes, followed by injection site cryotherapy.

18 , laser photocoagulation, thermotherapy, and cryotherapy.

19 or for which meta-analysis was performed was cryotherapy.

20 buckle limited to the area of the holes and cryotherapy.

21 Observation, excisional biopsy, and cryotherapy.

22 5%), topical interferon alfa-2b (0% vs 1%), cryotherapy (0% vs 3%), photodynamic therapy (0% vs 1%),

23 ed for laser ablation (1.69 [1.27-2.24]) and cryotherapy (1.84 [1.33-2.56]).

24 e methods (laser ablation: 1.05 [0.78-1.41]; cryotherapy: 1.01 [0.35-2.92]; and cold coagulation: 0.6

25 ence in the treatment failure prevalence for cryotherapy (13.9%, 95% CI 6.1-21.6) versus loop electro

26 tained: 483 313 injections, 19 257 lasers or cryotherapy, 14 949 RD repairs, and 9017 other vitrectom

27 ne-fourth of respondents reported performing cryotherapy (25.4% [95% CI, 14.7%-36.1%]), thermal ablat

28 ic therapy (0% vs 1%), excisional biopsy and cryotherapy (38% vs 65%), excisional biopsy and cryother

29 9%] vs 33.3% [95% CI, 16.0%-50.6%]; P = .03; cryotherapy: 40.5% [95% CI, 24.3%-56.8%] vs 6.7% [95% CI

30 treatment was wide excision with adjunctive cryotherapy (47.8%), followed by topical mitomycin C (30

31 kle and pneumatic retinopexy (both 11%), and cryotherapy (5%).

32 ST-AMGs were implanted after resection with cryotherapy: 5 conjunctival melanoma, 4 squamous cell ca

33 Overall, 756 women received cryotherapy, 629 (83.2%) of whom returned for their firs

34 Immediate management included cryotherapy (7/7 eyes), wound suturing (2/7 eyes), and i

35 Cryotherapy, a rapid and effective medical treatment uti

36 Radiofrequency or cryotherapy ablation of AF is a relatively new treatment

37 English were found that addressed the use of cryotherapy after oral surgical procedures.

38 linical trials that assessed the benefits of cryotherapy after oral surgical procedures.

39 tomy, and in 5-9% following brachytherapy or cryotherapy after prostate cancer.

40 cation (time on/off) or extended duration of cryotherapy after surgical procedures to attain the best

41 The MPT group required less laser and cryotherapy after treatment (32% of eyes vs. 50% of eyes

42 umatic retinopexy (3 patients), and laser or cryotherapy alone (2 patients).

43 pants, with a total of 2174 AKs treated with cryotherapy and 2170 AKs treated with PDT.

44 cases and in the presence of retinal breaks, cryotherapy and a segmental buckle limited to the retina

45 equivalent to conventional therapies such as cryotherapy and cantharidin.

46 mab or aflibercept or conbercept or laser or cryotherapy and gender or sex or male or female and medi

47 Cryotherapy and heat therapy are popular strategies in t

48 In recent years, improvements in cryotherapy and HIFU have increased efficacy whereas dec

49 While cryotherapy and irreversible electroporation are the pri

50 ucity of level I evidence directly comparing cryotherapy and laser treatment for threshold ROP, the l

51 all randomized trials that directly compared cryotherapy and laser.

52 higher (CIN2+) has not been compared between cryotherapy and loop electrosurgical excision procedure

53 psy was a possible option for 9/22 (41%) and cryotherapy and Mitomycin C for 6/22 (27%) respondents.

54 e in AL and myopic shift was associated with cryotherapy and more extensive segmental buckling.

55 a novel framework for advancing research in cryotherapy and neuromodulation.

56 Cryotherapy and photocoagulation provide excellent contr

57 d cryotherapy dosage protocol led to shorter cryotherapy and procedure times, with equal safety, and

58 Of the various ablation techniques, cryotherapy and radiofrequency ablation are being increa

59 rapies, antiangiogenic agents, radiotherapy, cryotherapy and some chemotherapies.

60 successfully with laser photocoagulation or cryotherapy and subsequently underwent cataract surgery.

61 complete excision with appropriate adjuvant cryotherapy and topical chemotherapy may be curative in

62 e investigations into comparing or combining cryotherapy and topical solutions that can support patie

63 es 67141 (prophylaxis of retinal detachment, cryotherapy) and 67145 (prophylaxis of retinal detachmen

64 for IL Sb, 4 of 20 (20%; 95% CI, 8%-42%) for cryotherapy, and 5 of 30 (17%; 95% CI, 7%-34%) for place

65 biopsies were obtained followed by cervical cryotherapy, and in Arm B, women with abnormal cytology

66 clude observation or wide excisional biopsy, cryotherapy, and reconstruction, possibly with amniotic

67 The durability of renal cryotherapy appears promising.

68 ith respect to biochemical recurrence rates, cryotherapy appears to be as effective for low-risk pros

69 In early-stage esophageal cancer, spray cryotherapy appears to have a unique role, eliminating m

70 d improved patient selection, the results of cryotherapy are becoming more promising.

71 formal radiation therapy, brachytherapy, and cryotherapy) are gaining popularity, despite the lack of

72 study; mean (SD) age was 37 (8) years in the cryotherapy arm and 38 (9) years in the LEEP arm.

73 hrHPV prevalence was 90% (160 of 177) in the cryotherapy arm and 94% (166 of 177) in the LEEP arm (P

74 Women were randomized to immediate cryotherapy (Arm A) or cytology-based screening (Arm B).

75 vent postoperative vitreous hemorrhage using cryotherapy around sclerotomy sites and/or endolaser in

76 ults suggest that clinicians should consider cryotherapy as an alternative treatment to initial radia

77 ell carcinoma underwent local resection with cryotherapy as primary treatment.

78 divided into 2 groups: Cryo group (receiving cryotherapy as the only form of retinopexy) and Laser gr

79 Thick AKs (Olsen grade II-III) received cryotherapy at months 6 and 9; test areas were otherwise

80 s plana route with concomitant triple-freeze cryotherapy at the injection site during needle withdraw

81 avitreal injections (code 67028), lasers and cryotherapy (codes 67141, 67145, and 67228), retinal det

82 The long-term biochemical outcomes following cryotherapy compare favorably to those achieved with rad

83 vitreous cell and CME for those treated with cryotherapy compared to controls were 4.73 (95% confiden

84 mes generally were seen in eyes treated with cryotherapy compared with eyes undergoing laser treatmen

85 A recent randomized trial of cryotherapy compared with radiation therapy shows simila

86 s in the New World, the combined placebo and cryotherapy cure rate (18%; 95% CI, 10%-31%) is likely t

87 at presentation, initial treatment (laser or cryotherapy), date of LSV, date of lensectomy (if perfor

88 g/mm(2) of lesion area on days 1, 3, and 5), cryotherapy (days 1 and 14), and placebo cream (daily fo

89 +/- 1.6) received a 15 minute bout of local cryotherapy, delivered via ice cup massage over the ante

90 Technical improvements in cryotherapy delivery systems have reduced the complicati

91 The new time-to-effect-based cryotherapy dosage protocol led to shorter cryotherapy a

92 e noninferiority of a novel, individualized, cryotherapy-dosing strategy for each vein.

93 The optimal dosage of cryotherapy during cryoballoon ablation of pulmonary vei

94 Cryotherapy (e.g., ice pack) is prescribed commonly afte

95 MR imaging can be used to estimate cryotherapy effects and guide therapy intraprocedurally.

96 Because of logistical difficulties with cryotherapy (eg, the necessity, costs, and supply chain

97 nuous passive motion, preoperative exercise, cryotherapy, electrotherapy, and acupuncture.

98 Cryotherapy failure was defined as an increasing postcry

99 All patients received oral cryotherapy for 30 minutes with each dose of 5FU.

100 ents who underwent 83 primary excisions with cryotherapy for conjunctival PAM who had adequate tissue

101 ns, this work has the potential to stimulate cryotherapy for in vivo drug delivery.

102 of eyes with a history of laser retinopexy, cryotherapy for retinal tear, or RD repair was determine

103 Analysis of data from the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) an

104 In the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (ROP), 4099 i

105 ere participants in the multicenter study of Cryotherapy for Retinopathy of Prematurity.

106 rowth factor, laser photocoagulation, and/or cryotherapy for ROP were identified.

107 Key recommendations include the following: cryotherapy for scattered actinic keratosis (AK); field

108 ze the recent literature on endoscopic spray cryotherapy for the treatment of Barrett's esophagus and

109 n clearance at 3 months after treatment than cryotherapy for thin AKs on the face and scalp.

110 Focal cryotherapy for unilateral disease offers the added bene

111 local treatments, intralesional (IL) Sb and cryotherapy, for single lesions due to Bolivian Leishman

112 Cryotherapy greatly reduces sexual function.

113 VA improved over time in the cryotherapy group (slope of -0.0018 logMAR units per mon

114 60.8 months (range 8.1-223.1 months) in the cryotherapy group and 45.0 months (range 3.1-339.0 month

115 hology and death due to other causes) in the cryotherapy group and in 30 women (38 events, including

116 rted in 120 (60%) of 200 participants in the cryotherapy group, 123 (64%) of 192 in the thermal ablat

117 206 (84%) participants in the cryotherapy group, 197 (81%) in the thermal ablation gro

118 after the procedure (six [2%] of 250 in the cryotherapy group, four [2%] of 250 in the thermal ablat

119 after the procedure (one [<1%] of 241 in the cryotherapy group, none of 242 in the thermal ablation g

120 ocular complications were identified in the cryotherapy group.

121 who had been treated using laser therapy or cryotherapy (group 1), patients with regressed ROP who h

122 Over 2 years, 60 women (30%) randomized to cryotherapy had recurrent CIN grade 2 or higher vs 37 (1

123 edures for the treatment of prostate cancer, cryotherapy has become a feasible option as a viable alt

124 Focal cryotherapy has encouraging short-term efficacy in terms

125 Cryotherapy has undergone considerable change.

126 Technological improvements in cryotherapy have increased its use, and long-term data o

127 options for focal therapy are available with cryotherapy having the most clinical experience.

128 options for focal therapy are available with cryotherapy having the most clinical experience.

129 among those who underwent LEEP compared with cryotherapy (hazard ratio, 1.40; 95% CI, 1.03-1.90; P =

130 both eyes and who were randomized to receive cryotherapy in 1 eye.

131 Management included excisional biopsy with cryotherapy in 23 cases (72%) and observation in 9 cases

132 pillary thermotherapy (TTT) in 18 (56%), and cryotherapy in 24 (75%) eyes.

133 out the practical disadvantages of providing cryotherapy in an LMIC.

134 yobiology open up new opportunities to apply cryotherapy in combination with chemotherapy or radiothe

135 nconclusive, and the biochemical etiology of cryotherapy in human skeletal muscle remains largely unk

136 nclude brachytherapy, local resection and/or cryotherapy in selected cases.

137 nclude the application of various lasers and cryotherapy in the vicinity of the cleft.

138 No evidence was found to indicate that cryotherapy increased the rate of color vision deficits

139 ods of aspiration with or without adjunctive cryotherapy, intracameral cautery, or photocoagulation.

140 eous and anogenital wart treatments, such as cryotherapy, intralesional immunotherapy, and prescripti

141 ive factors such as resection margin, use of cryotherapy, intraoperative ultrasound, and blood loss.

142 Initial management included cryotherapy, intravitreal injection of bevacizumab, plaq

143 Salvage cryotherapy is a minimally invasive alternative to salva

144 Cryotherapy is a popular strategy for the treatment of s

145 Endoscopic spray cryotherapy is a promising ablative modality for treatme

146 Endoscopic spray cryotherapy is a relatively new ablative modality for th

147 Excision with cryotherapy is an effective treatment for the majority o

148 Cryotherapy is commonly used in the treatment of skeleta

149 Bottom Line: Oral cryotherapy is effective for the prevention of oral muco

150 hlight that treatment with tremelimumab plus cryotherapy is feasible and modulates the immune microen

151 However, the data to support the use of cryotherapy is inconclusive, and the biochemical etiolog

152 Cryotherapy is more feasible in resource-limited setting

153 Whole-gland cryotherapy is ready for prime time based on favorable b

154 Cryotherapy is standard practice for treating patients w

155 lter the FAF findings, including vitrectomy, cryotherapy, laser photocoagulation, or photodynamic the

156 st (83%) also received ophthalmic treatment (cryotherapy, laser photocoagulation, thermotherapy, or p

157 in the number of complications after modern cryotherapy leads to a better quality of life, which may

158 Cryotherapy may also be performed percutaneously with ma

159 Adjunctive cryotherapy may be beneficial in cases with poor initial

160 Two hours after cryotherapy, muscle biopsies were obtained to analyze ch

161 on (n = 3), photodynamic therapy (n = 1), or cryotherapy (n = 1) for tumor control.

162 ctor agents (n = 4), vitrectomy (n = 2), and cryotherapy (n = 1).

163 9%), external beam radiotherapy (n = 1, 3%), cryotherapy (n = 1, 3%), or palliative chemotherapy (n =

164 grade 2 or 3 were randomized 1:1 to receive cryotherapy (n = 200) or LEEP (n = 200) and were followe

165 luded excisional biopsy (n = 4), followed by cryotherapy (n = 3) and/or brachytherapy (n = 3).

166 Cryotherapy of fibroadenomas is a safe, effective, and v

167 Surgical resection or cryotherapy of hepatic metastasis from colorectal cancer

168 MR imaging-guided percutaneous cryotherapy of liver tumors is feasible and safe.

169 ences were attributable to skin biopsies and cryotherapy of premalignant lesions.

170 MR imaging-guided percutaneous cryotherapy of renal tumors shows promise for the treatm

171 Current salvage cryotherapy of the prostate can result in undetectable s

172 Cryotherapy of the prostate represents a potential treat

173 avirus (hrHPV) testing followed by immediate cryotherapy of women with hrHPV (HPV screen-and-treat) m

174 The Cryotherapy On-Line Data Registry (COLD Registry) used t

175 focal therapy (TFT) using the modalities of cryotherapy or high intensity focused ultrasound as an a

176 iode laser thermotherapy for all of them and cryotherapy or intravitreal chemotherapy for 10 (32%) an

177 atal treatment, and 13% (32 of 250) received cryotherapy or laser ablation for ROP.

178 al period, and 13% of eyes (30) had neonatal cryotherapy or laser ablation for ROP.

179 gas into the vitreous cavity, combined with cryotherapy or laser retinopexy and followed by postoper

180 Women were randomized 1:1 to receive cryotherapy or LEEP and were followed up every 6 months

181 es collected before and after treatment with cryotherapy or LEEP.

182 The World Health Organization recommends cryotherapy or loop electrosurgical excision procedure (

183 C associated with diode laser thermotherapy, cryotherapy, or both at 4-week intervals (3-6 cycles).

184 ed participants (1:1:1) to thermal ablation, cryotherapy, or large loop excision of the transformatio

185 Excisional biopsy, cryotherapy, oral cimetidine, topical or injection inter

186 ng data for local ablative therapies such as cryotherapy; other indications for surgery; and the gamm

187 Cryotherapy, plaque radiotherapy, external beam radiothe

188 nce of >= 3 retinal breaks, history of prior cryotherapy, presence of choroidal detachment, or durati

189 ts receiving treatment for cancer, does oral cryotherapy prevent oral mucositis?

190 Cryotherapy procedures declined across all indications.

191 A clinically relevant dose of cryotherapy produced negligible acute biochemical and mo

192 ses indicate that the Cambridge prophylactic cryotherapy protocol is safe and markedly reduces the ri

193 y and efficacy of the Cambridge prophylactic cryotherapy protocol, a standardized retinal prophylacti

194 Spray cryotherapy rapidly cools tissues by spraying them with

195 Cryotherapy reduced levels of hexose sugars and hypoxant

196 cold therapy, and two studies indicated that cryotherapy reduced post-surgical edema and pain.

197 HPV infection compared with those undergoing cryotherapy, reinforcing the efficacy of LEEP in this po

198 de 2 or 3, treatment with LEEP compared with cryotherapy resulted in a significantly lower rate of ce

199 MR imaging-guided percutaneous cryotherapy resulted in no serious complications and no

200 Physiological studies indicated cryotherapy resulted in vasoconstriction, reduction of e

201 No randomized trial evaluated brachytherapy, cryotherapy, robotic radical prostatectomy, or photon-be

202 y, rhegmatogenous retinal detachment, use of cryotherapy, scleral buckling at the time of pars plana

203 A single-visit approach with VIA and cryotherapy seems to be safe, acceptable, and feasible i

204 The subset of patients cured by salvage cryotherapy seems to be small, and patient selection is

205 seemed to be consensus among clinicians that cryotherapy should be applied for 10 to 20 minutes follo

206 Focal cryotherapy shows promising early results with potency r

207 Focal cryotherapy shows very high potency rates and warrants f

208 Treatment with adjuvant cryotherapy significantly decreased the risk of tumor re

209 ammation and achieve beneficial results with cryotherapy, skin temperature (normally 33 degrees C) ne

210 P at presentation, prior treatment (laser or cryotherapy), subsequent retinal surgeries, presence of

211 ies of the prostate appears to be higher for cryotherapy than for initial radiation therapy.

212 ere no more likely in eyes that had received cryotherapy than in control eyes.

213 rall, 88% were eligible for and 68% received cryotherapy the same day: 10 cases were clinically suspi

214 Compared with cryotherapy, the pooled relative risk for the meta-analy

215 atment involves topical therapies, including cryotherapy, thermotherapy and/or intralesional injectio

216 the study group had a significantly shorter cryotherapy time (28.3+/-7 versus 19.4+/-4.3 minutes; P<

217 ms have reduced the complications of primary cryotherapy to a low and acceptable level.

218 ution was conducted to compare the effect of cryotherapy to eyes with pars planitis to those receivin

219 biopsy, limited superficial keratectomy, and cryotherapy to the remaining conjunctival margins.

220 OP has evolved from later, more destructive (cryotherapy) to earlier, less destructive (LASER therapy

221 of threshold ROP and treatment with laser or cryotherapy (treated group) and those with regressed ROP

222 chamber cell, vitreous cell, and CME in the cryotherapy-treated eyes.

223 e of positive post-treatment biopsies in the cryotherapy-treated patients.

224 n up to 87-98% of patients after one or more cryotherapy treatments.

225 rostatectomy local therapy (radiotherapy and cryotherapy) underwent dual-time-point (18)F-fluciclovin

226 The choice of cryotherapy versus endolaser retinopexy was observed to

227 Very low-certainty evidence showed that cryotherapy was associated with a reduction in opioid co

228 Cryotherapy was associated with greater increase in AL (

229 grees C, each application lasting for 40 s), cryotherapy was carried out using the double-freeze tech

230 e seen on ultrasound biomicroscopy, targeted cryotherapy was performed.

231 Both VIA and cryotherapy were highly acceptable to the patients (over

232 All recurrences of OSSN after excision and cryotherapy were noted and categorized in relation to cl

233 Ks are thick in which case field therapy and cryotherapy were recommended; combination lesion directe

234 reated with excisional biopsy and adjunctive cryotherapy were retrospectively reviewed.

235 ); retinal ablation (laser photocoagulation, cryotherapy)] were evaluated.

236 rally treated with wide surgical margins and cryotherapy, whereas unexpected OSSN with pterygia was t

237 ternal beam radiotherapy, brachytherapy, and cryotherapy will be reviewed.

238 otherapy (38% vs 65%), excisional biopsy and cryotherapy with adjuvant oral cimetidine (8% vs 9%), an

239 tidine (8% vs 9%), and excisional biopsy and cryotherapy with adjuvant topical or injection interfero

240 d clinical trials was a direct comparison of cryotherapy with laser.

241 Excisional biopsy and cryotherapy with or without adjuvant oral cimetidine and

242 eyes, PPV alone was performed in 6 eyes, and cryotherapy with pneumatic retinopexy was performed in 1

243 this review, we discuss contemporary data on cryotherapy with specific focus on studies using the new

244 least until study conclusion, for lasers and cryotherapy, with a maximal 79.6% decrease (from a mean

245 al ablation has similar treatment success to cryotherapy, without the practical disadvantages of prov

246 determine how a clinically-relevant dose of cryotherapy would impact the transcriptome and metabolom